Welcome to our dedicated page for Transdigm Group SEC filings (Ticker: TDG), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
TransDigm Group Incorporated filings document operating results, material events and capital-structure activity for an aerospace components company listed on the New York Stock Exchange under TDG. Form 8-K reports include quarterly financial results, conference-call materials, acquisition-related events and exhibits furnished with company press releases.
The filing record also covers financing arrangements at subsidiary TransDigm Inc., including senior subordinated notes, term loans, indenture and guarantee disclosures. Governance filings report annual meeting voting outcomes, director elections, auditor ratification and advisory executive-compensation votes, alongside common-stock registration details and other material agreements.
A shareholder has filed a notice of proposed sale of 17,526 shares of common stock under Rule 144. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $23,438,045.58, compared with 56,318,584 shares of the same class reported as outstanding. The seller acquired these 17,526 shares on 12/04/2025 through a cash exercise of stock options on that date.
Over the past three months, the person for whose account the securities are to be sold, identified in multiple entries as The Fortuna Trust U/T/A DTD 06/01/2018, has already sold several blocks of common stock under a Rule 10b5-1 plan, including 7,191 shares on 11/18/2025 for $9,791,047.47 and 4,592 shares on 11/28/2025 for $6,248,486.61. By signing the notice, the seller represents that they do not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
TransDigm Group Inc. insider transaction: A company officer serving as Co‑Chief Operating Officer reported an option exercise and related stock sale. On 12/01/2025, the insider exercised a stock option to acquire 290 shares of TransDigm common stock at an exercise price of $269.42 per share, then on the same date sold 290 shares of common stock at a price of $1,351.06 per share.
After these transactions, the insider directly beneficially owned 1,055 shares of TransDigm common stock and 1,740 stock options. The filing was made as a Form 4 by one reporting person, reflecting routine insider equity activity.
TDG received a Form 144 notice indicating a planned sale of common stock under Rule 144. A holder intends to sell 290 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $394,449.30. The issuer had 56,318,584 common shares outstanding at the time referenced.
The 290 shares to be sold were acquired on 12/01/2025 by exercising stock options from the issuer, paid in cash on the same date. Over the prior three months, 10b5-1 sales for Patrick J. Murphy included 290 common shares on 11/03/2025 for $379,900.00 and 580 common shares on 10/27/2025 for $785,760.80.
TransDigm Group Inc. filed a Form 4 reporting equity transactions by director Kevin Stein through the Fortuna Trust dated June 1, 2018. On 11/28/2025, the trust exercised a stock option for 4,592 shares of TransDigm common stock at an exercise price of $105.88 per share. The option relates to an award originally exercisable from 09/30/2018 and expiring on 04/25/2028, and its exercise price has been adjusted for dividends declared since August 1, 2022.
On the same date, the trust reported sales of TransDigm common stock in three transactions of 2,997, 1,545 and 50 shares at volume-weighted average prices of approximately $1,360.44, $1,361.25 and $1,362.43, respectively, within narrow intraday price ranges. Following these transactions, the Fortuna Trust indirectly held 8,158 shares of TransDigm common stock.
A shareholder affiliated with NYSE: TDG has filed a Form 144 notice covering the planned sale of 4,592 shares of common stock. The shares are to be sold through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of 6,222,205.92 reported in the notice, compared with 56,318,584 shares outstanding. The seller acquired these 4,592 shares on the same date via a cash exercise of stock options.
The filing also lists a series of prior Rule 10b5-1 plan sales over the past three months by The Fortuna Trust, each disclosing the number of common shares sold and the gross proceeds on specific dates in October and November 2025. The signer represents they are not aware of undisclosed material adverse information about the issuer’s current or prospective operations.
TransDigm Group Inc. (TDG) director Kevin Stein, through the Fortuna Trust dated June 1, 2018, reported stock option exercises and related share sales. On 11/25/2025, the trust exercised 4,187 stock options at an exercise price of $105.88 per share and then sold 4,097 common shares at a weighted average price of $1,360.5495 per share, plus an additional 90 shares at a weighted average price of $1,361.8702 per share. On 11/26/2025, the trust exercised another 30 stock options at $105.88 per share and sold 30 shares at $1,360.06 per share. After these transactions, the trust beneficially owned 8,158 TDG common shares and 60,058 stock options indirectly.
A selling stockholder of TransDigm Group Inc. (TDG) filed a Form 144 notice to sell 4,187 common shares through Morgan Stanley Smith Barney LLC on the NYSE. The shares have an indicated aggregate market value of $5,592,827.12, while 56,318,584 common shares were shown as outstanding; this is a baseline figure, not the amount being sold. The shares to be sold were acquired on 11/25/2025 by exercising stock options for cash on the same date.
The notice also lists prior Rule 10b5-1 plan sales over the past three months for The Fortuna Trust U/T/A DTD 06/01/2018, including 7,191 shares sold on 10/18/2025 for gross proceeds of $9,791,047.47 and 1,104 shares sold on 11/20/2025 for $1,502,423.47. By signing, the seller represents they are not aware of undisclosed material adverse information about TransDigm’s operations.
TransDigm Group Inc. (TDG) director Michael Graff reported a gift of 340 shares of common stock on 11/21/2025, as shown on this Form 4. The transaction, coded "G" for gift, was at a reported price of $0 per share.
After this transaction, Graff directly owns 1,653 TransDigm common shares. He also reports indirect ownership of 5,096 shares held by The 2012 Carol Ostrow GST Trust created by his spouse for their children, and 7,000 shares held by certain other trusts created for the benefit of their children, for which he serves as trustee.
TransDigm Group (TDG) director Form 4 shows an option exercise and matching share sale by an affiliated trust. On 11/21/2025, the Fortuna Trust dated June 1, 2018 exercised 230 stock options for TransDigm common stock at an exercise price of $105.88 per share and acquired 230 shares. The trust then sold 230 common shares at an average price of $1,360.3096 per share, leaving it with 8,158 shares of indirect beneficial ownership. Following the transaction, the trust continues to hold 64,275 stock options indirectly, with an exercise price of $105.88 and an expiration date of 04/25/2028.
TransDigm Group (TDG) has a Form 144 notice for the potential sale of 230 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE. The filing lists an aggregate market value of $305,410.10 for these shares and notes that 56,318,584 common shares were outstanding at the time referenced. The 230 shares were acquired on 11/21/2025 by exercising stock options for cash on the same date.
The notice also details recent activity under a Rule 10b5-1 trading plan for The Fortuna Trust, including common stock sales of 1,104 shares on 11/20/2025, 7,191 shares on 11/18/2025, and 700 shares on 10/27/2025, with disclosed gross proceeds for each transaction. The signatory represents that they are not aware of undisclosed material adverse information about the issuer.